The natural course of chronic hepatitis C: Implications for clinical practice

Journal of Viral Hepatitis

Volumn 5, Issue SUPPL. 1, 1998, Pages 9-12

  Dusheiko, G M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Hepatitis C; Natural history

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGE; ALCOHOL ABUSE; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE COURSE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

AGE FACTORS; ALANINE TRANSAMINASE; BIOPSY; DISEASE PROGRESSION; EUROPE; FIBROSIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; POPULATION SURVEILLANCE;

EID: 0031782190     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.0050s1009.x     Document Type: Article

References (15)

1. Seeff LB. Chronic hepatitis C. Beware the older drinking male: Fibrosis progression beckons! Comments. Hepatology 1997; 26: 1074-6.
2. Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26: 21S-28S.
3. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-6.
4. Seeff LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906-11.
5. Patel A, Sherlock S, Dusheiko G, Scheuer PJ, Ellis LA, Ashrafzadeh P. Clinical course and histological correlations in post-transfusion hepatitis C. The Royal Free Hospital experience. Eur J Gastroent Hepatol 1991; 3: 491-5.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
7. Darby SC, Ewart DW, Giangrande PL et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997; 350: 1425-31.
8. Simmonds P, Mellor J, Craxi A et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996; 24: 517-24.
9. Mathurin P, Moussalli J, Cadranel JF et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998; 27: 868-72.
10. Heathcote EJ, Keeffe EB, Lee SS et al. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology 1998; 27: 1136-43.
11. Keeffe EB, Hollinger FB, Bailey R et al. Therapy of hepatitis C. Consensus interferon trials. Hepatology 1997; 26: 101S-107S.
12. Tong MJ, Reddy KR, Lee WM et al. Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial. Hepatology 1997; 26: 747-54.
13. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C. Morphometric analysis of repeated biopsies. Hepatology 1997; 25: 1028-31.
14. Yano M, Kumada H, Kage M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
15. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C. a retrospective follow-up study of 384 patients [see Comments]. Gastroenterology 1997; 112: 463-72.